Histogenics Corporation NeoCart Cartilage Therapy Found Promising in OHSU Study

WALTHAM, MASSACHUSETTS, September 26, 2007– Histogenics’ NeoCart® neocartilage implant is safe and shows promise, according to Dennis Crawford, MD, PhD, of Oregon Health & Science University (OHSU) in a presentation at the International Cartilage Repair Society Annual Meeting (ICRS) in Warsaw, Poland on September 30, 2007.

MORE ON THIS TOPIC